Role of NRSF/REST in the regulation of cardiac gene expression and function

Circulation Journal

Volumn 77, Issue 11, 2013, Pages 2682-2686

  Kuwahara, Koichiro ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Atrial natriuretic factor; Brain natriuretic peptide; Heart failure; Remodeling

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; BRG1 PROTEIN; CALCIUM CHANNEL T TYPE; HISTONE DEACETYLASE; HISTONE H3; IVABRADINE;

3' UNTRANSLATED REGION; ARTICLE; DNA FLANKING REGION; GENE EXPRESSION REGULATION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE TACHYCARDIA; HUMAN; NONHUMAN; NRSF GENE; PHENOTYPE; PROTEIN EXPRESSION; REPRESSOR GENE; REST GENE; UPREGULATION;

ADULT; CALCIUM CHANNELS, T-TYPE; DEATH, SUDDEN, CARDIAC; GENE EXPRESSION REGULATION; HEART FAILURE; HUMANS; MUSCLE PROTEINS; MYOCARDIUM; REPRESSOR PROTEINS; VENTRICULAR REMODELING;

EID: 84886501227     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-13-1210     Document Type: Article

References (34)

1. Nair AP, Timoh T, Fuster V. Contemporary medical management of systolic heart failure. Circ J 2012; 76: 268-277.
2. Hill JA, Olson EN. Cardiac plasticity. N Engl J Med 2008; 358: 1370-1380.
3. Mentz RJ, Felker GM. Natriuretic peptide-guided therapy for heart failure. Circ J 2011; 75: 2031-2037.
4. McKinsey TA, Olson EN. Toward transcriptional therapies for the failing heart: Chemical screens to modulate genes. J Clin Invest 2005; 115: 538-546.
5. Morimoto T, Sunagawa Y, Fujita M, Hasegawa K. Novel heart failure therapy targeting transcriptional pathway in cardiomyocytes by a natural compound, curcumin. Circ J 2010; 74: 1059-1066.
6. Oka T, Xu J, Molkentin JD. Re-employment of developmental transcription factors in adult heart disease. Semin Cell Dev Biol 2007; 18: 117-131.
7. Kuwahara K, Saito Y, Ogawa E, Takahashi N, Nakagawa Y, Naruse Y, et al. The neuron-restrictive silencer element-neuron-restrictive silencer factor system regulates basal and endothelin 1-inducible atrial natriuretic peptide gene expression in ventricular myocytes. Mol Cell Biol 2001; 21: 2085-2097.
8. Ogawa E, Saito Y, Kuwahara K, Harada M, Miyamoto Y, Hamanaka I, et al. Fibronectin signaling stimulates BNP gene transcription by inhibiting neuron-restrictive silencer element-dependent repression. Cardiovasc Res 2002; 53: 451-459.
9. Kuwahara K, Saito Y, Takano M, Arai Y, Yasuno S, Nakagawa Y, et al. NRSF regulates the fetal cardiac gene program and maintains normal cardiac structure and function. EMBO J 2003; 22: 6310-6321.
10. Houweling AC, van Borren MM, Moorman AF, Christoffels VM. Expression and regulation of the atrial natriuretic factor encoding gene Nppa during development and disease. Cardiovasc Res 2005; 67: 583-593.
11. Ooi L, Wood IC. Chromatin crosstalk in development and disease: Lessons from rest. Nat Rev Genet 2007; 8: 544-554.
12. Bingham AJ, Ooi L, Wood IC. Multiple chromatin modifications important for gene expression changes in cardiac hypertrophy. Biochem Soc Trans 2006; 34: 1138-1140.
13. Nakagawa Y, Kuwahara K, Harada M, Takahashi N, Yasuno S, Adachi Y, et al. Class II HDACs mediate CaMK-dependent signaling to NRSF in ventricular myocytes. J Mol Cell Cardiol 2006; 41: 1010-1022.
14. Montgomery RL, Davis CA, Potthoff MJ, Haberland M, Fielitz J, Qi X, et al. Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. Genes Dev 2007; 21: 1790-1802.
15. Klose RJ, Zhang Y. Regulation of histone methylation by demethylimination and demethylation. Nat Rev Mol Cell Biol 2007; 8: 307-318.
16. McKinsey TA, Zhang CL, Lu J, Olson EN. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 2000; 408: 106-111.
17. Schoenherr CJ, Paquette AJ, Anderson DJ. Identification of potential target genes for the neuron-restrictive silencer factor. Proc Natl Acad Sci USA 1996; 93: 9881-9886.
18. Yasuno S, Usami S, Kuwahara K, Nakanishi M, Arai Y, Kinoshita H, et al. Endogenous cardiac natriuretic peptides protect the heart in a mouse model of dilated cardiomyopathy and sudden death. Am J Physiol Heart Circ Physiol 2009; 296: H1804-H1810.
19. Takano M, Kinoshita H, Shioya T, Itoh M, Nakao K, Kuwahara K. Pathophysiological remodeling of mouse cardiac myocytes expressing dominant negative mutant of neuron restrictive silencing factor. Circ J 2010; 74: 2712-2719.
20. Robinson RB, Siegelbaum SA. Hyperpolarization-activated cation currents: From molecules to physiological function. Annu Rev Physiol 2003; 65: 453-480.
21. Wahl-Schott C, Biel M. Hcn channels: Structure, cellular regulation and physiological function. Cell Mol Life Sci 2009; 66: 470-494.
22. Cerbai E, Mugelli A. I(f) in non-pacemaker cells: Role and pharmacological implications. Pharmacol Res 2006; 53: 416-423.
23. Kuratomi S, Kuratomi A, Kuwahara K, Ishii TM, Nakao K, Saito Y, et al. Nrsf regulates the developmental and hypertrophic changes of hcn4 transcription in rat cardiac myocytes. Biochem Biophys Res Commun 2007; 353: 67-73.
24. Kuratomi S, Ohmori Y, Ito M, Shimazaki K, Muramatsu S, Mizukami H, et al. The cardiac pacemaker-specific channel Hcn4 is a direct transcriptional target of MEF2. Cardiovasc Res 2009; 83: 682-687.
25. Stillitano F, Lonardo G, Zicha S, Varro A, Cerbai E, Mugelli A, et al. Molecular basis of funny current (If) in normal and failing human heart. J Mol Cell Cardiol 2008; 45: 289-299.
26. Kuwabara Y, Kuwahara K, Takano M, Kinoshita H, Arai Y, Yasuno S, et al. Increased expression of HCN channels in the ventricular myocardium contributes to enhanced arrhythmicity in mouse failing hearts. J Am Heart Assoc 2013; 2: e000150, doi:10.1161/JAHA.113.000150.
27. Heusch G. Heart rate and heart failure: Not a simple relationship. Circ J 2011; 75: 229-236.
28. Swedberg K, Komajda M, Bohm M, Borer JS, Ford I, Dubost-Brama A, et al. Ivabradine and outcomes in chronic heart failure (SHIFT): A randomised placebo-controlled study. Lancet 2010; 376: 875-885.
29. Kuwahara K, Takano M, Nakao K. Pathophysiological significance of t-type Ca2+ channels: Transcriptional regulation of T-type Ca2+ channel-regulation of CACNA1H by neuron-restrictive silencer factor. J Pharmacol Sci 2005; 99: 211-213.
30. Ono K, Iijima T. Cardiac T-type Ca(2+) channels in the heart. J Mol Cell Cardiol 2010; 48: 65-70.
31. Yasui K, Niwa N, Takemura H, Opthof T, Muto T, Horiba M, et al. Pathophysiological significance of T-type Ca2+ channels: Expression of T-type Ca2+ channels in fetal and diseased heart. J Pharmacol Sci 2005; 99: 205-210.
32. Niwa N, Yasui K, Opthof T, Takemura H, Shimizu A, Horiba M, et al. Cav3.2 subunit underlies the functional T-type Ca2+ channel in murine hearts during the embryonic period. Am J Physiol Heart Circ Physiol 2004; 286: H2257-H2263.
33. 2+ channels and heart failure. Proc Assoc Am Physicians 1999; 111: 429-437.
34. Kinoshita H, Kuwahara K, Takano M, Arai Y, Kuwabara Y, Yasuno S, et al. T-type Ca2+ channel blockade prevents sudden death in mice with heart failure. Circulation 2009; 120: 743-752.